Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
Digestive Diseases and Sciences|August 22, 2022
Best Practices in Treatment of Laryngopharyngeal Reflux Disease: A Multidisciplinary Modified Delphi StudyAfrin N Kamal, Shumon I Dhar, Jonathan M Bock, et al.
Blood Cancer Journal|November 13, 2023
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort studyAllison M Bock, Jennifer J Gile, Melissa C Larson, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 27, 2021
Impact of subspecialty training on management of laryngopharyngeal reflux: results of a worldwide surveyJerome R Lechien, Thomas L Carroll, Jacqueline E Allen, et al.
Blood Advances|April 26, 2024
Defining primary refractory large B-cell lymphomaAllison M Bock, Raphael Mwangi, Yucai Wang, et al.
Atherosclerosis|September 26, 2006
LipoCardium: endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesionsPaulo I Homem de Bittencourt, Denise J Lagranha, Alexandre Maslinkiewicz, et al.
Blood|September 5, 2021
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AMLFei Yang, Nicola Long, Tauangtham Anekpuritanang, et al.
Science (New York, N.Y.)|February 22, 2020
Old carbon reservoirs were not important in the deglacial methane budgetM N Dyonisius, V V Petrenko, A M Smith, et al.
Hematological Oncology|November 29, 2024
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment ResistanceAllison M Bock, Kerstin Wenzl, Joseph P Novak, et al.
Blood Cancer Journal|July 12, 2025
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphomaJanek S Walker, Kerstin Wenzl, Joseph P Novak, et al.
Blood Advances|June 9, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamabAllison M Bock, Lei Feng, Ayushi Chauhan, et al.
Pageof 38